Astoria Portfolio Advisors Llc. Amgen Inc Transaction History

Astoria Portfolio Advisors Llc.

  • $274 Million
  • Q2 2024

A detailed history of Astoria Portfolio Advisors Llc. transactions in Amgen Inc stock. As of the latest transaction made, Astoria Portfolio Advisors Llc. holds 2,515 shares of AMGN stock, worth $838,098. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,515
Previous 2,513 0.08%
Holding current value
$838,098
Previous $714,000 9.94%
% of portfolio
0.29%
Previous 0.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024
BUY
$262.75 - $319.31 $525 - $638
2 Added 0.08%
2,515 $785,000
Q1 2024

Apr 16, 2024
BUY
$268.87 - $324.56 $2,957 - $3,570
11 Added 0.44%
2,513 $714,000
Q4 2023

Feb 07, 2024
SELL
$255.7 - $288.46 $126,571 - $142,787
-495 Reduced 16.52%
2,502 $720,000
Q3 2023

Oct 27, 2023
SELL
$218.65 - $271.46 $106,482 - $132,201
-487 Reduced 13.98%
2,997 $805,000
Q2 2023

Jul 14, 2023
BUY
$214.27 - $253.37 $61,281 - $72,463
286 Added 8.94%
3,484 $773,000
Q1 2023

Apr 05, 2023
SELL
$225.79 - $275.2 $6,322 - $7,705
-28 Reduced 0.87%
3,198 $773,000
Q4 2022

Jan 23, 2023
BUY
$229.03 - $291.01 $104,208 - $132,409
455 Added 16.42%
3,226 $0
Q3 2022

Nov 03, 2022
BUY
$224.46 - $253.15 $186,301 - $210,114
830 Added 42.76%
2,771 $625,000
Q2 2022

Jul 07, 2022
BUY
$230.71 - $256.74 $78,441 - $87,291
340 Added 21.24%
1,941 $472,000
Q1 2022

Jun 01, 2022
SELL
$219.27 - $242.57 $83,541 - $92,419
-381 Reduced 19.22%
1,601 $387,000
Q4 2021

Jun 01, 2022
BUY
$198.88 - $227.6 $394,180 - $451,103
1,982 New
1,982 $446,000

Others Institutions Holding AMGN

# of Institutions
2,969
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.61M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Astoria Portfolio Advisors Llc. Portfolio

Follow Astoria Portfolio Advisors Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Astoria Portfolio Advisors Llc., based on Form 13F filings with the SEC.

News

Stay updated on Astoria Portfolio Advisors Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email